DOI: http://dx.doi.org/10.18203/2349-3933.ijam20191170

Evaluation of carotid intima media thickness and associated risk factors in patients with chronic kidney disease: a cross sectional study

Mote Srikanth, Jeyapalan Kuppusamy, Hemachandar Radhakrishnan, Arun Prasath Palamalai

Abstract


Background: Chronic kidney disease is distinguished by progressive loss of kidney function over a period of years in the end leading to irreversible kidney failure. CKD is a significant prognosticator of cardiovascular disease. Atherosclerosis is common in patients with risk factors associated with chronic kidney disease.

Methods: It was a cross sectional study on CKD patients in a tertiary care hospital. About 90 CKD stage 3-5 patients aged above 18 years were enrolled in the study. Serum lipid profile, RFT, serum calcium, phosphorous, and BP were estimated among all the patient. Patient risk factors were noted and CIMT levels were compared accordingly.

Results: Out of 90 patients, males were predominant. There was a significant positive correlation between stage 5 and CIMT (P value <0.001). Mean CIMT was higher in patients with type 2 Diabetes. Patients with higher phosphorous the mean CIMT was significantly higher.

Conclusions: The CIMT is early marker for atherosclerosis. Author observed it was significantly higher in patients with stage 3 and 5 CKD. CIMT is a non- invasive marker which should be done in all patients with CKD which is cost effective.


Keywords


Blood pressure, Chronic kidney disease, Carotid intima media thickness, Renal function tests

Full Text:

PDF

References


Sarnak MJ. Cardiovascular complications in chronic kidney disease. Am J Kidney Dis. 2003;41:11-7.

Yeun JY, Levine RA, Mantadilok V, Kaysen GA. C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis. 2000;35(3):469-76.

Stefanovic V, Milojkovic M. Treatment of dyslipidemia in chronic kidney disease. Inter J Artificial Organs. 2004;27(10):821-7.

Song EY, McClellan WM, McClellan A, Gadi R, Hadley AC, Krisher J, et al. Effect of community characteristics on familial clustering of end-stage renal disease. Am J Nephrol. 2009;30(6):499-504.

Iseki K. Factors influencing the development of end-stage renal disease. Clin Exp Nephrol. 2005;9(1):5-14.

Kazancioğlu R. Risk factors for chronic kidney disease: an update. Kidney Inter Supp. 2013;3(4):368-71.

Bleyer AJ, Shemanski LR, Burke GL, Hansen KJ, Appel RG. Tobacco, hypertension, and vascular disease: Risk factors for renal functional decline in an older population. Kidney Int. 2000;57(5):2072–9.

McClellan WM, Flanders WD. Risk factors for progressive chronic kidney disease. Journal of the Am Soc Nephrol. 2003;14(suppl 2):S65-70.

Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. New Eng J Med. 2004;351(13):1285-95.

Paul J, Shaw K, Dasgupta S, Ghosh MK. Measurement of intima media thickness of carotid artery by B-mode ultrasound in healthy people of India and Bangladesh, and relation of age and sex with carotid artery intima media thickness: An observational study. J Cardiovascular Dis Res. 2012;3(2):128-31.

Kumar Vs, Kumar Ks, Lakshmi A, Srinivasa Rao PVL, Das G. Carotid intima-media thickness in patients with end-stage renal disease. Ind J Nephrol. 2009;19(1):13.

Lokesh S. A Comparative study of lipid profile and cardiovascular risk biomarkers among chronic haemodialysis patients and healthy individuals. J Clin Diagn Res, 2016. Available at: http://jcdr.net/article_fulltext.asp?issn=0973-709x&year=2016&volume=10&issue=9&page=OC15&issn=0973-709x&id=8523. Accessed 28 October 2018.

Marcos AG, Watanabe R, Lemos MM, Canziani ME. Evaluation of intima-media thickness in patients with chronic kidney disease not on dialysis: a prospective study of 24 month. Braz J Nephrol. 2014;36(1):35-41.

Dhivya P, Mathew KT. Effect of yoga therapy on fasting lipid profile in chronic kidney disease: a comparative study. Inter J Adv Med. 2018;5(2):1.

Schreier L, González AI, Elbert A, Berg G, Wikinski R. Utility of non-high-density lipoprotein cholesterol in hemodialyzed patients. Metab. 2004;53(8):1013-5.

Sharma VK, Dwivedi P, Dubey AK. Correlation of serum phosphate with carotid intimal-medial thickness in chronic kidney disease patients. Ind J Nephrol. 2014;24(1):15.

Ishimura E, Taniwaki H, Tabata T, Tsujimoto Y, Jono S, Emoto M, et al. Cross-sectional association of serum phosphate with carotid intima-medial thickness in hemodialysis patients. Am J Kidney Dis. 2005;45(5):859-65.

Afolabi OF, Ibewuike CU, Ulasi II, Arodiwe EB, Ijoma CK, Nwobodo MU, et al. Carotid Intima Media Thickness Measurements in Nigerian Pre-dialysis CKD Patients. J Med Sci Clin Res. 2018 Jul 2;6(7).